Developing treatments that withstand viral evolution is difficult. Here, the authors design ReconnAb-multimers: broad, highly potent therapeutics linking a non-neutralizing antibody, ACE2, and a multimerization domain to prepare for future pandemics.
- Ashley Utz
- Matt Armbrust
- Peter S. Kim